Stay updated on Cabozantinib in Advanced Soft Tissue Sarcoma Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib in Advanced Soft Tissue Sarcoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib in Advanced Soft Tissue Sarcoma Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-06-13T20:26:24.000Z thumbnail image
  4. Check
    4 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    10 days ago
    Change Detected
    Summary
    The value 7 on the webpage has recently changed to 8, representing a study focusing on the effectiveness of cabozantinib for soft tissue sarcomas that have not responded to standard treatments.
    Difference
    0.1%
    Check dated 2024-06-06T14:19:25.000Z thumbnail image
  7. Check
    25 days ago
    Change Detected
    Summary
    The webpage's 'Participation Criteria' section has been updated to provide detailed eligibility criteria for participants, specifying that researchers are looking for individuals with histologically or cytologically confirmed metastatic or unresectable soft tissue sarcoma. Previously, this section indicated that no information was provided about collaborators.
    Difference
    54%
    Check dated 2024-05-22T20:55:52.000Z thumbnail image
  8. Check
    46 days ago
    Change Detected
    Difference
    0.5%
    Check dated 2024-04-30T22:31:41.000Z thumbnail image

Stay in the know with updates to Cabozantinib in Advanced Soft Tissue Sarcoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib in Advanced Soft Tissue Sarcoma Clinical Trial page.